Obid, Rahib .

HRN: 23-94-87  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/18/2025
03/25/2025
IV
4.5gm
Q8h
Infectious Endocarditis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Cardiovascular    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: